02 December 2019 : Meta-Analysis
Comparison of Regorafenib, Fruquintinib, and TAS-102 in Previously Treated Patients with Metastatic Colorectal Cancer: A Systematic Review and Network Meta-Analysis of Five Clinical Trials
DOI: 10.12659/MSM.918411
Med Sci Monit 2019; 25:9179-9191
HTML version available soon